Publishers face antitrust lawsuit with potential implications for peer review, duplicate submission, and dissemination practices.

IF 2.7 Health affairs scholar Pub Date : 2025-02-05 eCollection Date: 2025-02-01 DOI:10.1093/haschl/qxaf018
Gregory Curfman
{"title":"Publishers face antitrust lawsuit with potential implications for peer review, duplicate submission, and dissemination practices.","authors":"Gregory Curfman","doi":"10.1093/haschl/qxaf018","DOIUrl":null,"url":null,"abstract":"<p><p>Scientific, technical, and medical (STM) publishers follow 3 basic tenets: (1) no compensation for peer reviewers; (2) manuscript submission only to one journal; and (3) no dissemination of manuscripts while under review. An antitrust lawsuit was filed in federal district court against STM publishers challenging these tenets. The lawsuit will have important implications for how STM research is published and will also affect authors and editors. Academic researchers (plaintiffs) who have served as authors and reviewers allege that the 6 largest STM publishers (defendants) have conspired to require authors to abide by the 3 basic tenets. The plaintiffs argue that the publishers have substantial market power, pursue anticompetitive policies, and violate Section 1 of the Sherman Antitrust Act. This article focuses principally on the second tenet, that research manuscripts may be submitted to only one journal. This requirement, which the plaintiffs believe is an antitrust violation, is not a feature of law journals, where multiple simultaneous submissions of manuscripts are a central part of the publishing process. This article will explain how the court may approach the legal analysis in this lawsuit and the important implications of the outcome of this litigation for the scholarly publishing ecosystem.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"3 2","pages":"qxaf018"},"PeriodicalIF":2.7000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11823101/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health affairs scholar","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/haschl/qxaf018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Scientific, technical, and medical (STM) publishers follow 3 basic tenets: (1) no compensation for peer reviewers; (2) manuscript submission only to one journal; and (3) no dissemination of manuscripts while under review. An antitrust lawsuit was filed in federal district court against STM publishers challenging these tenets. The lawsuit will have important implications for how STM research is published and will also affect authors and editors. Academic researchers (plaintiffs) who have served as authors and reviewers allege that the 6 largest STM publishers (defendants) have conspired to require authors to abide by the 3 basic tenets. The plaintiffs argue that the publishers have substantial market power, pursue anticompetitive policies, and violate Section 1 of the Sherman Antitrust Act. This article focuses principally on the second tenet, that research manuscripts may be submitted to only one journal. This requirement, which the plaintiffs believe is an antitrust violation, is not a feature of law journals, where multiple simultaneous submissions of manuscripts are a central part of the publishing process. This article will explain how the court may approach the legal analysis in this lawsuit and the important implications of the outcome of this litigation for the scholarly publishing ecosystem.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
出版商面临反垄断诉讼,可能涉及同行评议、副本提交和传播实践。
科学、技术和医学(STM)出版商遵循3条基本原则:(1)对同行评议者不予补偿;(2)稿件只投一种期刊;(三)审稿期间不得传播。针对挑战这些原则的STM出版商,联邦地区法院提起了反垄断诉讼。这起诉讼将对STM研究的发表方式产生重要影响,也将影响作者和编辑。曾担任作者和审稿人的学术研究人员(原告)声称,6家最大的STM出版商(被告)合谋要求作者遵守3条基本原则。原告认为出版商拥有巨大的市场力量,奉行反竞争政策,违反了《谢尔曼反托拉斯法》第1条。本文主要关注第二项原则,即研究稿件只能提交给一家期刊。原告认为这一要求违反了反垄断法,并不是法律期刊的特征,在法律期刊中,同时提交多份手稿是出版过程的核心部分。本文将解释法院如何在这起诉讼中进行法律分析,以及这起诉讼的结果对学术出版生态系统的重要影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Impact of US government funding freezes on the HIV response: findings from a rapid survey in 32 countries. The timeliness of health plan drug coverage policy changes to FDA label revisions. Shared labor-Public Private Partnerships for Maternal Health Equity. State laws that address workplace violence in health care settings. Correction to: Insulin rationing in states with and without insulin copay caps: a cross-sectional study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1